Market Overview

UPDATE: Canaccord Genuity Downgrades USANA Health Sciences to Hold on Management Transition

Related USNA
Top Performing Industries For November 10, 2015
Canaccord Reduces Target On USANA Health Ahead Of Q3 Results

Canaccord Genuity reduced its rating on USANA Health Sciences (NYSE: USNA) from Buy to Hold and lowered its price target from $60 to $40.

Canaccord Genuity commented, "While the beginnings of improvement in US sales trends and a modest valuation had attracted us to USNA shares, we expect that another management transition is likely to inhibit a normalization of the valuation. … While USNA's valuation is modest, and even discounted relative to its peers, we expect added organizational risk will lead to a perpetuated valuation discount and the shares could lag its peers in any normalization of the sector valuations."

USANA Health Sciences closed at $38.42 on Thursday.

Latest Ratings for USNA

Sep 2015DA DavidsonUpgradesNeutralBuy
Aug 2015DA DavidsonDowngradesBuyNeutral
Jun 2015DA DavidsonInitiates Coverage onBuy

View More Analyst Ratings for USNA
View the Latest Analyst Ratings

Posted-In: Canaccord GenuityAnalyst Color Downgrades Pre-Market Outlook Analyst Ratings


Related Articles (USNA)

View Comments and Join the Discussion!

Get Benzinga's Newsletters